Hong Kong, China – 2 February, 2015 - Shanghai MicroPort Orthopedics Co ("MicroPort Orthopedics") announced that its second generation medial-pivot Evolution™ Medial-Pivot Knee System ("Evolution™") was officially launched in Hong Kong.
The Evolution™ builds on over 16 years of excellent clinical history of the Advance® Medial-Pivot Knee System ("Advance®") which was launched in 1998. Up to date, more than 96,000 Advance® have been implanted worldwide. Peer-reviewed literature has shown the Advance® to be more stable and patient-preferred compared to traditional total knee implants.
Compared to the Advance®, the Evolution™ includes advancements in implant function and fit. It is differentiated through anatomic features that reproduce natural movement and stability, resulting in function more like a normal healthy knee. To offer better implant fit for patients, the Evolution™ features an expanded number of implant sizes and the anatomic tibial base.
"The Evolution™ is designed to replicate the movement and stability of a normal, healthy knee by incorporating a patented ball-in-socket feature on the medial side. As it is designed based on the success of the Advance®, I'm very confident in the clinical result of the Evolution™," said Professor Peter KY Chiu from Department of Orthopaedics & Traumatology of the University of Hong Kong, Queen Mary Hospital. "The Evolution™ features high flexion stability, low bone cut and low wear. For surgeons, it's an important system for clinical study of total knee replacement. For patients, it would offer a more stable and natural feel during normal daily activities after surgery."
"The Evolution™ is the only medial-pivot knee in the world that has gained FDA's approval for market launch and we believe its launch in the Hong Kong market will reinforce the brand image and increase market share for MicroPort Orthopedics," said Simon Chen, Vice President of Marketing and Sales of MicroPort Orthopedics. "We will continue to develop safe and high-quality products to offer innovative solutions for surgeons and patients."